"Breakthrough Treatment for Pancreatic Cancer Shows Promise in Extending Survival"
Scientists from Queen Mary University of London have discovered that targeting the molecule CD73 can hinder the harmful activity of amoeboid cells, which promote the spread of pancreatic cancer and weaken the immune system. This finding offers a promising new approach for treating pancreatic cancer, which has low survival rates. Blocking CD73 reduced the spread of cancer to the liver and decreased the number of immune cells supporting the tumor in mice. While further research is needed in humans, drugs blocking CD73 are already being tested in clinical trials for various types of cancer.